Huifang Lv Yunduan He Caiyun Nie Feng Du Xiaobing Chen
10.3389/fphar.2022.1067557
Front Pharmacol
2023 Jan 9;13:1067557.
apatinib camrelizumab case report gastric cancer literature review resistance trastuzumab
CC BY
https://pubmed.ncbi.nlm.nih.gov/36699065/
Case Reports
PMC9868577
36699065
Adding of apatinib and camrelizumab to overcome de novo trastuzumab resistance of HER2-positive gastric cancer: A case report and literature review
2023